Search

Tandem Diabetes Care Inc

Abierto

SectorSanidad

16.85 -3.55

Resumen

Variación precio

24h

Actual

Mínimo

16.95

Máximo

17.75

Métricas clave

By Trading Economics

Ingresos

-20M

-20M

Ventas

-43M

247M

BPA

-0.3

Margen de beneficios

-8.249

Empleados

2,500

EBITDA

-25M

-14M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+70.28% upside

Dividendos

By Acuity

Próximas Ganancias

6 ago 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-121M

1.2B

Apertura anterior

20.4

Cierre anterior

16.85

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

145 / 340 Clasificación en Healthcare

Tandem Diabetes Care Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

21 jul 2026, 19:06 UTC

Tandem Diabetes Care is lower today, driven by declines in the Health Care Equipment sub-sector. The asset has fallen steadily after an early high.

20 jul 2026, 17:26 UTC

Tandem Diabetes Care Inc shares are higher today, recovering from an early dip. The stock has gained significantly since last month’s close.

Comparación entre iguales

Cambio de precio

Tandem Diabetes Care Inc previsión

Precio Objetivo

By TipRanks

70.28% repunte

Estimación a 12 Meses

Media 29.97 USD  70.28%

Máximo 55 USD

Mínimo 15.5 USD

De acuerdo con 16 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Tandem Diabetes Care Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

16 ratings

10

Comprar

6

Mantener

0

Vender

Sentimiento

By Acuity

145 / 340 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.